Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.462, 2004-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Insulin glargine superior long-term therapy for type 2 DM in Europe
Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. :
Access to resources
Recommend
Insulin therapy decreases long-term costs in type 2 DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 426, 2003-01 ,pp. :
Premixed insulin analogues worth it in the long term in type 2 DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 490, 2005-01 ,pp. :
Add-on insulin glargine enhances HRQOL in type 2 DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 490, 2005-01 ,pp. :
ICERs favour long-term insulin glargine for diabetes
Inpharma, Vol. 1, Iss. 1580, 2007-01 ,pp. :